Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for intravenous administration. It is commonly associated with clot-busting therapy and is manufactured by Boehringer Ingelheim International Gmbh.

Actilyse is primarily used to dissolve blood clots in conditions like ischemic stroke and pulmonary embolism. It works by breaking down fibrin, a key component of blood clots, to restore blood flow. This medication is often administered in emergency settings to manage acute cardiovascular events.

Common effects of Actilyse may include bleeding at the injection site or other areas of the body. Patients might also experience allergic reactions, which can range from mild to severe. Monitoring for signs of bleeding is crucial during treatment.

Actilyse should be handled with care, as it can increase the risk of bleeding. Patients with a history of bleeding disorders or recent surgery should use it cautiously. Always follow healthcare provider instructions for safe administration and monitoring.

Actilyse may interact with anticoagulants, antiplatelet drugs, and other medications that affect blood clotting. Alcohol and certain supplements can also influence its effects. Consult a healthcare provider before combining Actilyse with other treatments.